Whether R&D expenditures are expensed or capitalized significantly impacts current-period profit. The same investment can either reduce this year's profit if expensed, or spread the cost over future years if capitalized. This choice is legitimate; the boundary lies in whether it truly meets the criteria, not in how much profit the company wants to report for the current year.
1. The five conditions are not merely formalities
Technical feasibility, intent to complete, ability to complete, and reliable measurement of economic benefits inflow must each be supported by evidence. Technical feasibility requires test reports or prototype validation; economic benefits require market assessment or existing orders as support. Capitalizing without evidence essentially defers the recognition of uncertainty.
II. Two Consequences After Capitalization
First, capitalized development expenses create future amortization pressure, deferring profit impact. Second, if a project is terminated, the unamortized balance must be written off in full—often in the least desirable quarter. Capitalization doesn't eliminate costs; it simply delays them.
III. Comparability Issues
Significant variation in capitalization ratios across peers means comparing net profit margins directly can lead to incorrect conclusions. To properly assess how much profit stems from accounting choices, first normalize the data to "total R&D spending as a percentage of revenue," then analyze the capitalization ratio.
IV. Recommendations for Internal Management
Maintain a project-level R&D ledger to document initiation, milestones, test results, and termination decisions. Assess capitalization ratios on a per-project basis rather than applying a blanket approach. Review the feasibility of capitalized projects quarterly and recognize impairments as necessary.
There is always room for accounting judgment, but room does not mean leeway. Clear evidence makes capitalization a reasonable allocation of time; without sufficient evidence, it is merely an advance on profits.